Matches in Wikidata for { <http://www.wikidata.org/entity/Q82314315> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q82314315 description "article scientifique publié en 2006" @default.
- Q82314315 description "artikull shkencor i botuar më 01 shkurt 2006" @default.
- Q82314315 description "artículu científicu espublizáu en febreru de 2006" @default.
- Q82314315 description "im Februar 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82314315 description "scientific article published on 01 February 2006" @default.
- Q82314315 description "wetenschappelijk artikel" @default.
- Q82314315 description "наукова стаття, опублікована в лютому 2006" @default.
- Q82314315 name "Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis" @default.
- Q82314315 name "Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis" @default.
- Q82314315 name "Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis" @default.
- Q82314315 type Item @default.
- Q82314315 label "Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis" @default.
- Q82314315 label "Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis" @default.
- Q82314315 label "Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis" @default.
- Q82314315 prefLabel "Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis" @default.
- Q82314315 prefLabel "Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis" @default.
- Q82314315 prefLabel "Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis" @default.
- Q82314315 P1433 Q82314315-771B0E2F-F7CA-482D-80B1-C5E97D6D3E72 @default.
- Q82314315 P1476 Q82314315-9B5E9455-10B7-462E-B3A9-E805E57F2E41 @default.
- Q82314315 P2093 Q82314315-B4216F9F-66BD-4047-8508-4BBCEE0F20E2 @default.
- Q82314315 P304 Q82314315-69EA14E3-EFDE-4C88-9309-DCE215E72573 @default.
- Q82314315 P31 Q82314315-D4B19DEE-844C-4D41-8664-A19E171E1434 @default.
- Q82314315 P356 Q82314315-6895E77F-89A7-4257-B4E7-E6B81BFE66AD @default.
- Q82314315 P433 Q82314315-12D4F2A0-A0FF-452D-BE40-65B48B233166 @default.
- Q82314315 P478 Q82314315-6A7FA084-BCA7-4809-A9A0-A3795D456B6F @default.
- Q82314315 P50 Q82314315-0C6A8693-1A9D-4CA3-99AE-CC403DECBE10 @default.
- Q82314315 P577 Q82314315-9C153A45-0D2C-4764-9A95-20593FC61E28 @default.
- Q82314315 P698 Q82314315-E9950F76-7F85-4E4A-B64F-4004302F0D5C @default.
- Q82314315 P921 Q82314315-12684237-AC55-4779-8592-AE62786A8E37 @default.
- Q82314315 P356 01.FPC.0000189801.96220.82 @default.
- Q82314315 P698 16424826 @default.
- Q82314315 P1433 Q10534561 @default.
- Q82314315 P1476 "Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis" @default.
- Q82314315 P2093 "David L Veenstra" @default.
- Q82314315 P304 "139-147" @default.
- Q82314315 P31 Q13442814 @default.
- Q82314315 P356 "10.1097/01.FPC.0000189801.96220.82" @default.
- Q82314315 P433 "2" @default.
- Q82314315 P478 "16" @default.
- Q82314315 P50 Q50592145 @default.
- Q82314315 P577 "2006-02-01T00:00:00Z" @default.
- Q82314315 P698 "16424826" @default.
- Q82314315 P921 Q1754768 @default.